EDGAR Filing Documents for 0001144204-09-004118

Form 8-K - Current report:

SEC Accession No. 0001144204-09-004118

Filing Date

2009-01-29

Accepted

2009-01-29 16:11:09

Documents

Period of Report

2009-01-23

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1		v138201_8k.htm	8-K	28536
2		v138201_ex10-1.htm	EX-10.1	18870
3		v138201_ex99-1.htm	EX-99.1	25327
	Complete submission text file	0001144204-09-004118.txt		74762

Mailing Address MIDDLE SECTION, LONGMAO STREET, AREA A LAIYANG WAIXIANGXING INDUSTRIAL PARK LAIYANG CITY, YANTAI F4 710075

Business Address MIDDLE SECTION, LONGMAO STREET, AREA A LAIYANG WAIXIANGXING INDUSTRIAL PARK LAIYANG CITY, YANTAI F4 710075 5619889880

Genesis Pharmaceuticals Enterprises, Inc. (Filer) CIK: 0001091164 (see all company filings)